The medication builds the bridge, therapy ensures long-term, sustainable recovery
She explains how an understanding of emotions can be leveraged to improve learning in kids and in adults, and how the education system should be altered to include new forms of exploration, rules, and emotional and social contexts to facilitate better learning and to include more diverse learning (and teaching) styles
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER In August, a Louisiana woman sued Novo Nordisk, the manufacturer of Ozempic and Wegovy, and Lilly, which makes another GLP-1 agonist, Mounjaro, claiming that the companies "downplayed the severity of gastrointestinal events caused by Ozempic and Mounjaro never, for example, warning of the risk of gastroparesis (paralyzed stomach) or gastroenteritis." The woman, who used Ozempic for more than a year before switching to Mounjaro last month, alleged she was "severely injured as a result" of using both drugs, the suit stated
Some individuals taking GLP-1 drugs like Ozempic and Wegovy have reported hair loss as a possible side effect
Int Rev Cytol 54:109160 Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimers disease
